Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Farlow

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Neurology|July 23, 1998
Pharmacologic treatment of cognition in Alzheimer's dementiaM R Farlow, R M Evans
Biochemistry International|December 1, 1992
The cholinergic agonist carbachol reduces intracellular beta-amyloid precursor protein in PC 12 and C6 cellsD K Lahiri, C Nall, M R Farlow
Brain Research. Molecular Brain Research|November 14, 1998
The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cellsD K Lahiri, M R Farlow, K Sambamurti
Drugs & Aging|February 1, 1997
Optimal management of behavioural disorders associated with dementiaC A Class, L Schneider, M R Farlow
Journal of Neuroscience Research|April 15, 1994
Tacrine alters the secretion of the beta-amyloid precursor protein in cell linesD K Lahiri, S Lewis, M R Farlow
The Journal of the Oklahoma State Medical Association|November 26, 1998
Recent advances in the treatment of Alzheimer'sR W Richter, M R Farlow, M J Farlow
Indiana Medicine : the Journal of the Indiana State Medical Association|September 1, 1987
Magnetic resonance in the evaluation of multiple sclerosisM R Farlow, J C Stevens, M K Edwards
The American Journal of Medicine|October 31, 1997
Potential role for estrogen replacement in the treatment of Alzheimer's dementiaL S Schneider, M R Farlow, J M Pogoda
AJR. American Journal of Roentgenology|September 1, 1986
Multiple sclerosis: MRI and clinical correlationM K Edwards, M R Farlow, J C Stevens
Annals of the New York Academy of Sciences|May 20, 2000
Effect of a memory-enhancing drug, AIT-082, on the level of synaptophysinD K Lahiri, Y W Ge, M R Farlow
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Neurology|July 23, 1998
Pharmacologic treatment of cognition in Alzheimer's dementiaM R Farlow, R M Evans
Biochemistry International|December 1, 1992
The cholinergic agonist carbachol reduces intracellular beta-amyloid precursor protein in PC 12 and C6 cellsD K Lahiri, C Nall, M R Farlow
Brain Research. Molecular Brain Research|November 14, 1998
The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cellsD K Lahiri, M R Farlow, K Sambamurti
Drugs & Aging|February 1, 1997
Optimal management of behavioural disorders associated with dementiaC A Class, L Schneider, M R Farlow
Journal of Neuroscience Research|April 15, 1994
Tacrine alters the secretion of the beta-amyloid precursor protein in cell linesD K Lahiri, S Lewis, M R Farlow
The Journal of the Oklahoma State Medical Association|November 26, 1998
Recent advances in the treatment of Alzheimer'sR W Richter, M R Farlow, M J Farlow
Indiana Medicine : the Journal of the Indiana State Medical Association|September 1, 1987
Magnetic resonance in the evaluation of multiple sclerosisM R Farlow, J C Stevens, M K Edwards
The American Journal of Medicine|October 31, 1997
Potential role for estrogen replacement in the treatment of Alzheimer's dementiaL S Schneider, M R Farlow, J M Pogoda
AJR. American Journal of Roentgenology|September 1, 1986
Multiple sclerosis: MRI and clinical correlationM K Edwards, M R Farlow, J C Stevens
Annals of the New York Academy of Sciences|May 20, 2000
Effect of a memory-enhancing drug, AIT-082, on the level of synaptophysinD K Lahiri, Y W Ge, M R Farlow
Pageof 12